ArticleFrontiers in pharmacology2026
Garlic-derived allyl sulfides attenuate house dust mite-induced allergic airway inflammation associated with reduced PI3K/NF-κB signaling.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Allergic asthma, characterized by chronic airway inflammation, is often triggered by Methods: BALB/c mice were sensitized and challenged to develop allergic asthma and administered with DATS, DADS, or SAC. Histological phenomena were examined using hematoxylin and eosin (H&E) staining. Bronchoalveolar lavage fluid (BALF) was analyzed for pro-inflammatory (TNF-α, IL-1β, IL-12) and anti-inflammatory (IL-10, TGF-β) cytokines, as well as Th1/Th2 markers (IFN-γ, IL-4, IL-5, and IL-13). Serum immunoglobulins, including IgE, IgG1, and IgG2a subclasses, were quantified. Parallel experiments using A549 alveolar epithelial cells examined PI3K/NF-κB signaling via Western blot analysis. Results: Among the tested compounds, SAC showed the strongest effects, significantly reducing inflammatory cell infiltration, restoring Th1/Th2 balance by elevating IFN-γ and reducing IL-4, IL-5, and IL-13, and lowering TNF-α, IL-1β, and TGF-β while enhancing IL-10. SAC also decreased total IgE and IgG1 while increasing IgG2a, suggesting a shift toward Th1-mediated immunity. In A549 cells, SAC inhibited Der p-induced PI3K and IKK expression and suppressed Akt and NF-κB phosphorylation, thereby reducing IL-6 expression. Both Conclusion: These findings demonstrate that SAC alleviates Der p-induced airway inflammation by modulating immune responses and downregulating PI3K/Akt/NF-κB signaling, highlighting its potential as a natural therapeutic agent for allergic asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.